A major advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This vital cancer protector protein is frequently inactivated in various forms of malignancies, resulting https://meshbookmarks.com/story22048666/nanobodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-tumor-therapy